|
Clinical Trial Working Groups
|
|
Goal for 2014: One concept from each institution.
To join a clinical trial working group, please contact Jessica Roy, Program Manager, at [email protected] or 317-634-5842 ext. 19. GU:
- Next Call: March 28, 2014
- Face to face meeting at GU ASCO in late January 2014.
- Concepts: Prostate trial (University of Michigan) in active development.
Thoracic:
- Next Call: April 10, 2014
- Kick-off teleconference held Jan. 10, 2014.
- Group co-chairs: Arkadiusz Dudek (University of Illinois) and Nasser Hanna (Indiana University).
- Concepts: NSCLC (Indiana University); renal LOI (University of Illinois).
GI:
- Kick-off teleconference held Feb. 21, 2014.
- Concepts: hepatocellular approved LOI (Indiana University).
|
Dr. Daniel Vaena is the new Steering Committee representative from the University of Iowa. Dr. Vaena's clinical expertise includes bladder, kidney, penile, prostate, and testicular cancers. Dr. Vaena takes over for Dr. Ray Hohl who is the new director of the Penn State Hershey Cancer Institute.
Dr. Bert H. O'Neil is the new Steering Committee representative from Indiana University. Dr. O'Neil's research interests include studying novel targeted therapies and combinations in patients with advanced malignancies, particularly gastrointestinal malignancies. Dr. O'Neil succeeds Dr. Noah Hahn who will direct the bladder cancer program at the Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center.
